76 related articles for article (PubMed ID: 22314759)
1. [Evaluation of anosognosia in Alzheimer's disease].
Turró-Garriga O; López-Pousa S; Vilalta-Franch J; Garre-Olmo J
Rev Neurol; 2012 Feb; 54(4):193-8. PubMed ID: 22314759
[TBL] [Abstract][Full Text] [Related]
2. Two dimensions of anosognosia in patients with Alzheimer's disease: reliability and validity of the Japanese version of the Anosognosia Questionnaire for Dementia (AQ-D).
Sato J; Nakaaki S; Murata Y; Shinagawa Y; Matsui T; Hongo J; Tatsumi H; Akechi T; Furukawa TA
Psychiatry Clin Neurosci; 2007 Dec; 61(6):672-7. PubMed ID: 18081630
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence of anosognosia in Alzheimer's disease].
Turró-Garriga O; Conde-Sala JL; Reñé-Ramírez R; López-Pousa S; Gascón-Bayarri J; Garre-Olmo J
Med Clin (Barc); 2014 Jul; 143(1):13-9. PubMed ID: 23830548
[TBL] [Abstract][Full Text] [Related]
4. Clinical differences in patients with Alzheimer's disease according to the presence or absence of anosognosia: implications for perceived quality of life.
Conde-Sala JL; Reñé-Ramírez R; Turró-Garriga O; Gascón-Bayarri J; Juncadella-Puig M; Moreno-Cordón L; Viñas-Diez V; Garre-Olmo J
J Alzheimers Dis; 2013; 33(4):1105-16. PubMed ID: 23128559
[TBL] [Abstract][Full Text] [Related]
5. Anosognosia in Alzheimer's disease: a study of associated factors.
Migliorelli R; Tesón A; Sabe L; Petracca G; Petracchi M; Leiguarda R; Starkstein SE
J Neuropsychiatry Clin Neurosci; 1995; 7(3):338-44. PubMed ID: 7580194
[TBL] [Abstract][Full Text] [Related]
6. Anosognosia and depression in patients with Alzheimer's dementia.
Verhülsdonk S; Quack R; Höft B; Lange-Asschenfeldt C; Supprian T
Arch Gerontol Geriatr; 2013; 57(3):282-7. PubMed ID: 23597486
[TBL] [Abstract][Full Text] [Related]
7. Burden associated with the presence of anosognosia in Alzheimer's disease.
Turró-Garriga O; Garre-Olmo J; Vilalta-Franch J; Conde-Sala JL; de Gracia Blanco M; López-Pousa S
Int J Geriatr Psychiatry; 2013 Mar; 28(3):291-7. PubMed ID: 22555993
[TBL] [Abstract][Full Text] [Related]
8. Anosognosia and Alzheimer's disease: the role of depressive symptoms in mediating impaired insight.
Smith CA; Henderson VW; McCleary CA; Murdock GA; Buckwalter JG
J Clin Exp Neuropsychol; 2000 Aug; 22(4):437-44. PubMed ID: 10923053
[TBL] [Abstract][Full Text] [Related]
9. Cognitive reserve and anosognosia in questionable and mild dementia.
Spitznagel MB; Tremont G
Arch Clin Neuropsychol; 2005 Jun; 20(4):505-15. PubMed ID: 15896563
[TBL] [Abstract][Full Text] [Related]
10. Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia.
Andersen CK; Wittrup-Jensen KU; Lolk A; Andersen K; Kragh-Sørensen P
Health Qual Life Outcomes; 2004 Sep; 2():52. PubMed ID: 15383148
[TBL] [Abstract][Full Text] [Related]
11. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
[TBL] [Abstract][Full Text] [Related]
12. [Validation of the Quality of Life in Alzheimer's Disease (QOL-AD) scale in Mexican patients with Alzheimer, vascular and mixed-type dementia].
Rosas-Carrasco O; Torres-Arreola Ldel P; Guerra-Silla Mde G; Torres-Castro S; Gutierrez-Robledo LM
Rev Neurol; 2010 Jul; 51(2):72-80. PubMed ID: 20602312
[TBL] [Abstract][Full Text] [Related]
13. Assessing quality of life in Taiwanese patients with Alzheimer's disease.
Fuh JL; Wang SJ
Int J Geriatr Psychiatry; 2006 Feb; 21(2):103-7. PubMed ID: 16416471
[TBL] [Abstract][Full Text] [Related]
14. Determinants of the discrepancy in patient- and caregiver-rated quality of life for persons with dementia.
Huang HL; Chang MY; Tang JS; Chiu YC; Weng LC
J Clin Nurs; 2009 Nov; 18(22):3107-18. PubMed ID: 19207789
[TBL] [Abstract][Full Text] [Related]
15. Anosognosia in Alzheimer's disease: the role of impairment levels in assessment of insight across domains.
Leicht H; Berwig M; Gertz HJ
J Int Neuropsychol Soc; 2010 May; 16(3):463-73. PubMed ID: 20188013
[TBL] [Abstract][Full Text] [Related]
16. [Methods for assessing impaired insight in Alzheimer's disease--a critical review].
Leicht H; Gertz HJ
Psychiatr Prax; 2009 Mar; 36(2):58-66. PubMed ID: 18726844
[TBL] [Abstract][Full Text] [Related]
17. Caregiver characteristics are associated with neuropsychiatric symptoms of dementia.
Sink KM; Covinsky KE; Barnes DE; Newcomer RJ; Yaffe K
J Am Geriatr Soc; 2006 May; 54(5):796-803. PubMed ID: 16696746
[TBL] [Abstract][Full Text] [Related]
18. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
19. Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up.
Turró-Garriga O; Garre-Olmo J; Calvó-Perxas L; Reñé-Ramírez R; Gascón-Bayarri J; Conde-Sala JL
J Alzheimers Dis; 2016; 51(2):357-66. PubMed ID: 26890611
[TBL] [Abstract][Full Text] [Related]
20. How does an Alzheimer's disease patient's role in medical decision making change over time?
Hirschman KB; Xie SX; Feudtner C; Karlawish JH
J Geriatr Psychiatry Neurol; 2004 Jun; 17(2):55-60. PubMed ID: 15157344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
